Public Health Strategies Can Use Low/no Calorie Sweeteners

Low/no-calorie sweeteners can make a massive impact on public health strategies and may curb diabetes and increase health awareness.

all of them have undergone an extensive safety evaluation process by food safety authorities globally prior to being approved for use on the market; - Have no adverse effect on blood glucose regulation in people with and without diabetes and lead to a lower blood glucose rise compared to sugar;

Screening for Diabetes - Test - Frequently Asked Questions
Diabetes screening is done using blood tests like fasting blood sugar and hemoglobin A1c levels. Diabetes affects 8.3% Americans and about 10% Indians.

‘Efforts should be made to understand and, where possible, reconcile policy discrepancies between organisations and reduce regulatory hurdles that impede product development and reformulation designed to reduce sugars and/or calories.’

Tweet it Now

(2) they have therefore a role to play in the dietary management of diabetes when used as substitutes for sugars; - Can help reduce net calorie intake while providing the desired sweet taste, when used in place of sugar to reduce energy density of foods and drinks; and - Can be part of the strategies to consider to reduce sugars intake, in line with public health recommendations worldwide aimed at reducing the risk and prevalence of obesity, a major public health concern.

While the reduction in the intake of sugars is being recommended around the world to address the increasing rates of obesity, the authors agree on the need for evidence-based communication to ensure more informed public health decisions and public attitudes towards low/no-calorie sweeteners.

Commenting on the paper, lead author Dr. Margaret Ashwell highlighted that: "The aim of our workshop was to stimulate forward-thinking as well as to restate principles. It is the consensus of the panel that the substantial body of evidence around low-calorie sweeteners' safety and role in helping people reduce their sugar and calorie intake, a public health priority, should be communicated in a consistent manner".

Gestational Diabetes About
The condition is not caused by a lack of insulin, but by the action of hormones produced during pregnancy that blocks the action of insulin.

Co-author Sigrid Gibson added: "We [the 17-panel experts] came together to discuss and debate what we really do know, what we don't yet know, and what should be done in relation to research on low-calorie sweeteners, in light of current public health policies. This experts' consensus is important because it provides clarity to communicators so that they know they can give a message with confidence. So, we hope that the recommendations arising from this workshop will assist policymakers and other stakeholders including NGOs, health professionals, research funding bodies and the food and beverage industry".

Provided that they are used in place of sugar and in the context of a healthy diet and lifestyle, the experts agree that low/no-calorie sweeteners have a beneficial role to play in helping achieve sugar and calorie intake reduction, which associated health gains cannot be ignored.

Latent Autoimmune Diabetes (LADA) - Facts, Diagnosis and Management
LADA or Latent Autoimmune Diabetes of Adulthood is a form of type 1 autoimmune diabetes that can be mistaken for type 2 diabetes because it develops in older adults.

They clarified that the benefit of using low/no-calorie sweeteners will depend on the amount of sugars replaced in the diet as well as the overall diet quality. As also stated by the experts' panel, the "Use of LCS [low calorie sweeteners] alone cannot be expected to act as a 'silver bullet' for weight loss". Nevertheless, and based on the robust scientific evidence considered, the authors concluded that low/no calorie sweeteners can be useful in dietary approaches to both prevent and manage diabetes and obesity, and can facilitate reduction in energy intake and weight loss.

Having discussed research priorities, and in line with other consensus of experts published recently(3,4), the panel agreed that future research should include well-designed, high-quality human studies to confirm long-term benefits of low/no calorie sweeteners. Furthermore, the report indicated the need for studies to model low/no calorie sweeteners' impact on sugar reduction and diet quality.

Metformin - Diabetes Drug with New Therapeutic Uses
Metformin, a century old anti-diabetic drug used commonly to bring down blood sugar levels has other therapeutic uses like treating PCOS, aging and obesity.

With regard to suggested actions, the group of experts pointed to the importance of effective communication strategies to inform consumers - to tackle misperceptions - as well as NGOs, health professionals, research funding bodies and the food and beverage industry. They further concluded that: "Efforts should be made to understand and, where possible, reconcile policy discrepancies between organisations and reduce regulatory hurdles that impede product development and reformulation designed to reduce sugars and/or calories."

Source-Eurekalert